Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Anticancer Drugs Market Research Report 2024

Global Anticancer Drugs Market Research Report 2024

Industry: Pharma & Healthcare

Published: 2024-02-18

Pages: 180 Pages

Report ld: 2237722

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global Anticancer Drugs market was valued at US$ 190,012 million in 2023 and is anticipated to reach US$ 391,003 million by 2030, witnessing a CAGR of 11.26% during the forecast period 2024-2030.

North American market for Anticancer Drugs is estimated to increase from $ 104,835 million in 2023 to reach $ 207,068 million by 2030, at a CAGR of 10.7% during the forecast period of 2024 through 2030.

Asia-Pacific market for Anticancer Drugs is estimated to increase from $ 39,518 million in 2023 to reach $ 89,042 million by 2030, at a CAGR of 12.38% during the forecast period of 2024 through 2030.

The global key manufacturers of Anticancer Drugs include Merck & Co, Bristol-Myers Squibb, Roche, Novartis, Johnson & Johnson, AstraZeneca, Pfizer, Amgen, Eli Lilly, etc. In 2023, the global top five players had a share approximately 55.06% in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Anticancer Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticancer Drugs.

The Anticancer Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anticancer Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Anticancer Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Report Metric
Details
Report Title
Global Anticancer Drugs Market Research Report 2024
Global Anticancer Drugs Companies Covered
AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, Merck KGaA, Seagen, Eli Lilly, Ono Pharmaceutical, Pfizer, GSK, Exelixis, Regeneron, Innovent, Hengrui Medicine
Global Anticancer Drugs Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anticancer Drugs Market, Segment by Type
Chemotherapy

Targeted Therapy

Cancer Immunotherapy

Other
Global Anticancer Drugs Market, Segment by Application
Lung Cancer

Breast Cancer

Prostate Cancer

Blood-related Cancer

Other
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anticancer Drugs manufacturers competitive landscape revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Revenue of Anticancer Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Table of Contents

 1 Anticancer Drugs Market Overview	1
    1.1 Product Definition	1
    1.2 Anticancer Drugs by Type	1
        1.2.1 Global Anticancer Drugs Market Value Comparison by Type (2024-2030)	2
        1.2.2 Chemotherapy	4
        1.2.3 Targeted Therapy	5
        1.2.4 Cancer Immunotherapy	6
    1.3 Anticancer Drugs by Application	8
        1.3.1 Global Anticancer Drugs Market Value by Application (2024-2030)	8
        1.3.2 Lung Cancer	11
        1.3.3 Breast Cancer	11
        1.3.4 Prostate Cancer	12
        1.3.5 Blood-related Cancer	13
    1.4 Global Anticancer Drugs Market Size Estimates and Forecasts	14
    1.5 Assumptions and Limitations	16

 2 Anticancer Drugs Market Competition by Manufacturers	18
    2.1 Global Anticancer Drugs Revenue Market Share by Manufacturers (2019-2024)	18
    2.2 Global Key Players of Anticancer Drugs, Industry Ranking, 2022 VS 2023 VS 2024	20
    2.3 Global Key Manufacturers of Anticancer Drugs, Market Area & Headquarters	21
    2.4 Global Key Manufacturers of Anticancer Drugs, Product Type	22
    2.5 Global Key Manufacturers of Anticancer Drugs, Founded Date	23
    2.6 Global Anticancer Drugs Market Competitive Situation and Trends	24
        2.6.1 Global Anticancer Drugs Market Concentration Rate	24
        2.6.2 The Global 5 and 10 Largest Anticancer Drugs Players Market Share by Revenue	25
        2.6.3 Global Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)	26
    2.7 Manufacturers Mergers & Acquisitions, Expansion Plans	27

 3 Global Anticancer Drugs Market Scenario by Region	30
    3.1 Global Anticancer Drugs Market Size by Region: 2019 Versus 2023 Versus 2030	30
    3.2 Global Anticancer Drugs Revenue by Region: 2019-2030	31
        3.2.1 Global Anticancer Drugs Revenue by Region: 2019-2024	31
        3.2.2 Global Anticancer Drugs Revenue by Region: 2025-2030	32
    3.3 North America Anticancer Drugs Market Facts & Figures by Country	33
        3.3.1 North America Anticancer Drugs Market Size by Country: 2019 VS 2023 VS 2030	33
        3.3.2 North America Anticancer Drugs Revenue by Country (2019-2030)	33
        3.3.3 U.S.	34
        3.3.4 Canada	35
        3.3.5 Mexico	35
    3.4 Europe Anticancer Drugs Market Facts & Figures by Country	36
        3.4.1 Europe Anticancer Drugs Market Size by Country: 2019 VS 2023 VS 2030	36
        3.4.2 Europe Anticancer Drugs Revenue by Country (2019-2030)	36
        3.4.3 Germany	38
        3.4.4 France	38
        3.4.5 U.K.	39
        3.4.6 Italy	39
        3.4.7 Russia	40
    3.5 Asia Pacific Anticancer Drugs Market Facts & Figures by Region	40
        3.5.1 Asia Pacific Anticancer Drugs Market Size by Region: 2019 VS 2023 VS 2030	40
        3.5.2 Asia Pacific Anticancer Drugs Revenue by Region (2019-2030)	41
        3.5.3 China	42
        3.5.4 Japan	43
        3.5.5 South Korea	43
        3.5.6 India	44
        3.5.7 Australia	44
        3.5.8 Southeast Asia	45
    3.6 South America Anticancer Drugs Market Facts & Figures by Country	45
        3.6.1 South America Anticancer Drugs Market Size by Country: 2019 VS 2023 VS 2030	45
        3.6.2 South America Anticancer Drugs Revenue by Country	46
        3.6.3 Brazil	46
    3.7 Middle East and Africa Anticancer Drugs Market Facts & Figures by Country	47
        3.7.1 Middle East and Africa Anticancer Drugs Market Size by Country: 2019 VS 2023 VS 2030	47
        3.7.2 Middle East and Africa Anticancer Drugs Revenue by Country	47
        3.7.3 Middle East	48
        3.7.4 Africa	49

 4 Segment by Type	50
    4.1 Global Anticancer Drugs Revenue by Type (2019-2024)	50
    4.2 Global Anticancer Drugs Revenue by Type (2025-2030)	50
    4.3 Global Anticancer Drugs Revenue Market Share by Type (2019-2030)	50

 5 Segment by Application	52
    5.1 Global Anticancer Drugs Revenue by Application (2019-2024)	52
    5.2 Global Anticancer Drugs Revenue by Application (2025-2030)	52
    5.3 Global Anticancer Drugs Revenue Market Share by Application (2019-2030)	52

 6 Key Companies Profiled	54
    6.1 Abbvie	54
        6.1.1 Abbvie Details	54
        6.1.2 Abbvie Major Business	54
        6.1.3 Abbvie Anticancer Drugs Product and Solutions	55
        6.1.4 Abbvie Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)	56
        6.1.5 Abbvie Recent Developments and Future Plans	56
    6.2 Johnson & Johnson	57
        6.2.1 Johnson & Johnson Details	57
        6.2.2 Johnson & Johnson Major Business	57
        6.2.3 Johnson & Johnson Anticancer Drugs Product and Solutions	58
        6.2.4 Johnson & Johnson Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)	61
        6.2.5 Johnson & Johnson Recent Developments and Future Plans	61
    6.3 Novartis	61
        6.3.1 Novartis Details	61
        6.3.2 Novartis Major Business	62
        6.3.3 Novartis Anticancer Drugs Product and Solutions	63
        6.3.4 Novartis Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)	65
        6.3.5 Novartis Recent Developments and Future Plans	65
    6.4 Gilead Sciences	67
        6.4.1 Gilead Sciences Details	67
        6.4.2 Gilead Sciences Major Business	67
        6.4.3 Gilead Sciences Anticancer Drugs Product and Solutions	68
        6.4.4 Gilead Sciences Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)	70
        6.4.5 Gilead Sciences Recent Developments and Future Plans	70
    6.5 Roche	71
        6.5.1 Roche Details	71
        6.5.2 Roche Major Business	71
        6.5.3 Roche Anticancer Drugs Product and Solutions	72
        6.5.4 Roche Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)	76
        6.5.5 Roche Recent Developments and Future Plans	76
    6.6 Bristol-Myers Squibb	78
        6.6.1 Bristol-Myers Squibb Details	78
        6.6.2 Bristol-Myers Squibb Major Business	78
        6.6.3 Bristol-Myers Squibb Anticancer Drugs Product and Solutions	79
        6.6.4 Bristol-Myers Squibb Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)	81
        6.6.5 Bristol-Myers Squibb Recent Developments and Future Plans	81
    6.7 Amgen	83
        6.7.1 Amgen Details	83
        6.7.2 Amgen Major Business	83
        6.7.3 Amgen Anticancer Drugs Product and Solutions	84
        6.7.4 Amgen Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)	85
        6.7.5 Amgen Recent Developments and Future Plans	86
    6.8 AstraZeneca	88
        6.8.1 AstraZeneca Details	88
        6.8.2 AstraZeneca Major Business	88
        6.8.3 AstraZeneca Anticancer Drugs Product and Solutions	89
        6.8.4 AstraZeneca Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)	91
        6.8.5 AstraZeneca Recent Developments and Future Plans	91
    6.9 Merck & Co	94
        6.9.1 Merck & Co Details	94
        6.9.2 Merck & Co Major Business	94
        6.9.3 Merck & Co Anticancer Drugs Product and Solutions	95
        6.9.4 Merck & Co Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)	96
        6.9.5 Merck & Co Recent Developments and Future Plans	97
    6.10 Takeda	98
        6.10.1 Takeda Details	98
        6.10.2 Takeda Major Business	98
        6.10.3 Takeda Anticancer Drugs Product and Solutions	99
        6.10.4 Takeda Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)	100
        6.10.5 Takeda Recent Developments and Future Plans	100
    6.11 Merck KGaA	103
        6.11.1 Merck KGaA Details	103
        6.11.2 Merck KGaA Major Business	103
        6.11.3 Merck KGaA Anticancer Drugs Product and Solutions	104
        6.11.4 Merck KGaA Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)	105
        6.11.5 Merck KGaA Recent Developments and Future Plans	106
    6.12 Seagen	107
        6.12.1 Seagen Details	107
        6.12.2 Seagen Major Business	107
        6.12.3 Seagen Anticancer Drugs Product and Solutions	108
        6.12.4 Seagen Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)	109
        6.12.5 Seagen Recent Developments and Future Plans	109
    6.13 Eli Lilly	111
        6.13.1 Eli Lilly Details	111
        6.13.2 Eli Lilly Major Business	111
        6.13.3 Eli Lilly Anticancer Drugs Product and Solutions	112
        6.13.4 Eli Lilly Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)	113
    6.14 Ono Pharmaceutical	114
        6.14.1 Ono Pharmaceutical Details	114
        6.14.2 Ono Pharmaceutical Major Business	114
        6.14.3 Ono Pharmaceutical Anticancer Drugs Product and Solutions	115
        6.14.4 Ono Pharmaceutical Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)	116
        6.14.5 Ono Pharmaceutical Recent Developments and Future Plans	116
    6.15 Pfizer	118
        6.15.1 Pfizer Details	118
        6.15.2 Pfizer Major Business	118
        6.15.3 Pfizer Anticancer Drugs Product and Solutions	119
        6.15.4 Pfizer Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)	121
        6.15.5 Pfizer Recent Developments and Future Plans	121
    6.16 GSK	123
        6.16.1 GSK Details	123
        6.16.2 GSK Major Business	123
        6.16.3 GSK Anticancer Drugs Product and Solutions	124
        6.16.4 GSK Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)	125
        6.16.5 GSK Recent Developments and Future Plans	125
    6.17 Exelixis	127
        6.17.1 Exelixis Details	127
        6.17.2 Exelixis Major Business	127
        6.17.3 Exelixis Anticancer Drugs Product and Solutions	128
        6.17.4 Exelixis Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)	129
        6.17.5 Exelixis Recent Developments and Future Plans	130
    6.18 Regeneron	131
        6.18.1 Regeneron Details	131
        6.18.2 Regeneron Major Business	131
        6.18.3 Regeneron Anticancer Drugs Product and Solutions	132
        6.18.4 Regeneron Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)	132
    6.19 Innovent	134
        6.19.1 Innovent Details	134
        6.19.2 Innovent Major Business	134
        6.19.3 Innovent Anticancer Drugs Product and Solutions	135
        6.19.4 Innovent Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)	136
    6.20 Hengrui Medicine	137
        6.20.1 Hengrui Medicine Details	137
        6.20.2 Hengrui Medicine Major Business	137
        6.20.3 Hengrui Medicine Anticancer Drugs Product and Solutions	138
        6.20.4 Hengrui Medicine Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)	138

 7 Industry Chain and Sales Channels Analysis	139
    7.1 Anticancer Drugs Industry Chain Analysis	139
    7.2 Anticancer Drugs Key Raw Materials	140
        7.2.1 Key Raw Materials	140
        7.2.2 Raw Materials Key Suppliers	141
    7.3 Anticancer Drugs Production Mode & Process	141
    7.4 Anticancer Drugs Sales and Marketing	142
        7.4.1 Anticancer Drugs Sales Channels	143
        7.4.2 Anticancer Drugs Distributors	144
    7.5 Anticancer Drugs Customers	146

 8 Anticancer Drugs Market Dynamics	148
    8.1 Anticancer Drugs Industry Trends	148
    8.2 Anticancer Drugs Market Drivers	149
    8.3 Anticancer Drugs Market Challenges	150
    8.4 Anticancer Drugs Market Restraints	151

 9 Research Findings and Conclusion	152

 10 Methodology and Data Source	154
    10.1 Methodology/Research Approach	154
        10.1.1 Research Programs/Design	154
        10.1.2 Market Size Estimation	155
        10.1.3 Market Breakdown and Data Triangulation	156
    10.2 Data Source	157
        10.2.1 Secondary Sources	157
        10.2.2 Primary Sources	158
    10.3 Author List	160
    10.4 Disclaimer	161

Table of Figures

Table 1. Global Anticancer Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)	2
Table 2. Global Anticancer Drugs Market Value by Application (2024-2030) & (US$ Million)	8
Table 3. Global Anticancer Drugs Revenue (US$ Million) by Manufacturers (2019-2024)	18
Table 4. Global Anticancer Drugs Revenue Share by Manufacturers (2019-2024)	19
Table 5. Global Key Players of Anticancer Drugs, Industry Ranking, 2022 VS 2023 VS 2024	20
Table 6. Global Key Manufacturers of Anticancer Drugs, Market Area & Headquarters	21
Table 7. Global Key Manufacturers of Anticancer Drugs, Product Type	22
Table 8. Global Key Manufacturers of Anticancer Drugs, Founded Date	23
Table 9. Global Manufacturers Market Concentration Ratio (CR5 and HHI)	24
Table 10. Global Anticancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anticancer Drugs as of 2023)	26
Table 11. Manufacturers Mergers & Acquisitions, Expansion Plans	27
Table 12. Global Anticancer Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030	30
Table 13. Global Anticancer Drugs Revenue by Region (2019-2024) & (US$ Million)	31
Table 14. Global Anticancer Drugs Revenue Market Share by Region (2019-2024)	32
Table 15. Global Anticancer Drugs Revenue by Region (2025-2030) & (US$ Million)	32
Table 16. Global Anticancer Drugs Revenue Market Share by Region (2025-2030)	32
Table 17. North America Anticancer Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)	33
Table 18. North America Anticancer Drugs Revenue by Country (2019-2024) & (US$ Million)	33
Table 19. North America Anticancer Drugs Revenue by Country (2025-2030) & (US$ Million)	33
Table 20. Europe Anticancer Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)	36
Table 21. Europe Anticancer Drugs Revenue by Country (2019-2024) & (US$ Million)	36
Table 22. Europe Anticancer Drugs Revenue by Country (2025-2030) & (US$ Million)	36
Table 23. Asia Pacific Anticancer Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)	40
Table 24. Asia Pacific Anticancer Drugs Revenue by Region (2019-2024) & (US$ Million)	41
Table 25. Asia Pacific Anticancer Drugs Revenue by Region (2025-2030) & (US$ Million)	41
Table 26. South America Anticancer Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)	45
Table 27. South America Anticancer Drugs Revenue by Country (2019-2024) & (US$ Million)	46
Table 28. South America Anticancer Drugs Revenue by Country (2025-2030) & (US$ Million)	46
Table 29. Middle East and Africa Anticancer Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)	47
Table 30. Middle East and Africa Anticancer Drugs Revenue by Country (2019-2024) & (US$ Million)	47
Table 31. Middle East and Africa Anticancer Drugs Revenue by Country (2025-2030) & (US$ Million)	47
Table 32. Global Anticancer Drugs Revenue (US$ Million) by Type (2019-2024)	50
Table 33. Global Anticancer Drugs Revenue (US$ Million) by Type (2025-2030)	50
Table 34. Global Anticancer Drugs Revenue Market Share by Type (2019-2024)	50
Table 35. Global Anticancer Drugs Revenue Market Share by Type (2025-2030)	51
Table 36. Global Anticancer Drugs Revenue (US$ Million) by Application (2019-2024)	52
Table 37. Global Anticancer Drugs Revenue (US$ Million) by Application (2025-2030)	52
Table 38. Global Anticancer Drugs Revenue Market Share by Application (2019-2024)	52
Table 39. Global Anticancer Drugs Revenue Market Share by Application (2025-2030)	53
Table 40. Abbvie Company Information, Head Office, and Major Competitors	54
Table 41. Abbvie Major Business	54
Table 42. Abbvie Anticancer Drugs Product and Solutions	55
Table 43. Abbvie Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)	56
Table 44. Abbvie Recent Developments and Future Plans	56
Table 45. Johnson & Johnson Company Information, Head Office, and Major Competitors	57
Table 46. Johnson & Johnson Major Business	57
Table 47. Johnson & Johnson Anticancer Drugs Product and Solutions	58
Table 48. Johnson & Johnson Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)	61
Table 49. Johnson & Johnson Recent Developments and Future Plans	61
Table 50. Novartis Company Information, Head Office, and Major Competitors	61
Table 51. Novartis Major Business	62
Table 52. Novartis Anticancer Drugs Product and Solutions	63
Table 53. Novartis Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)	65
Table 54. Novartis Recent Developments and Future Plans	65
Table 55. Gilead Sciences Company Information, Head Office, and Major Competitors	67
Table 56. Gilead Sciences Major Business	67
Table 57. Gilead Sciences Anticancer Drugs Product and Solutions	68
Table 58. Gilead Sciences Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)	70
Table 59. Gilead Sciences Recent Developments and Future Plans	70
Table 60. Roche Company Information, Head Office, and Major Competitors	71
Table 61. Roche Major Business	71
Table 62. Roche Anticancer Drugs Product and Solutions	72
Table 63. Roche Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)	76
Table 64. Roche Recent Developments and Future Plans	76
Table 65. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors	78
Table 66. Bristol-Myers Squibb Major Business	78
Table 67. Bristol-Myers Squibb Anticancer Drugs Product and Solutions	79
Table 68. Bristol-Myers Squibb Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)	81
Table 69. Bristol-Myers Squibb Recent Developments and Future Plans	81
Table 70. Amgen Company Information, Head Office, and Major Competitors	83
Table 71. Amgen Major Business	83
Table 72. Amgen Anticancer Drugs Product and Solutions	84
Table 73. Amgen Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)	85
Table 74. Amgen Recent Developments and Future Plans	86
Table 75. AstraZeneca Company Information, Head Office, and Major Competitors	88
Table 76. AstraZeneca Major Business	88
Table 77. AstraZeneca Anticancer Drugs Product and Solutions	89
Table 78. AstraZeneca Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)	91
Table 79. AstraZeneca Recent Developments and Future Plans	91
Table 80. Merck & Co Company Information, Head Office, and Major Competitors	94
Table 81. Merck & Co Major Business	94
Table 82. Merck & Co Anticancer Drugs Product and Solutions	95
Table 83. Merck & Co Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)	96
Table 84. Takeda Company Information, Head Office, and Major Competitors	98
Table 85. Takeda Major Business	98
Table 86. Takeda Anticancer Drugs Product and Solutions	99
Table 87. Takeda Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)	100
Table 88. Takeda Recent Developments and Future Plans	100
Table 89. Merck KGaA Company Information, Head Office, and Major Competitors	103
Table 90. Merck KGaA Major Business	103
Table 91. Merck KGaA Anticancer Drugs Product and Solutions	104
Table 92. Merck KGaA Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)	105
Table 93. Merck KGaA Recent Developments and Future Plans	106
Table 94. Seagen Company Information, Head Office, and Major Competitors	107
Table 95. Seagen Major Business	107
Table 96. Seagen Anticancer Drugs Product and Solutions	108
Table 97. Seagen Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)	109
Table 98. Seagen Recent Developments and Future Plans	109
Table 99. Eli Lilly Company Information, Head Office, and Major Competitors	111
Table 100. Eli Lilly Major Business	111
Table 101. Eli Lilly Anticancer Drugs Product and Solutions	112
Table 102. Eli Lilly Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)	113
Table 103. Ono Pharmaceutical Company Information, Head Office, and Major Competitors	114
Table 104. Ono Pharmaceutical Major Business	114
Table 105. Ono Pharmaceutical Anticancer Drugs Product and Solutions	115
Table 106. Ono Pharmaceutical Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)	116
Table 107. Ono Pharmaceutical Recent Developments and Future Plans	116
Table 108. Pfizer Company Information, Head Office, and Major Competitors	118
Table 109. Pfizer Major Business	118
Table 110. Pfizer Anticancer Drugs Product and Solutions	119
Table 111. Pfizer Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)	121
Table 112. Pfizer Recent Developments and Future Plans	121
Table 113. GSK Company Information, Head Office, and Major Competitors	123
Table 114. GSK Major Business	123
Table 115. GSK Anticancer Drugs Product and Solutions	124
Table 116. GSK Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)	125
Table 117. GSK Recent Developments and Future Plans	125
Table 118. Exelixis Company Information, Head Office, and Major Competitors	127
Table 119. Exelixis Major Business	127
Table 120. Exelixis Anticancer Drugs Product and Solutions	128
Table 121. Exelixis Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)	129
Table 122. Exelixis Recent Developments and Future Plans	130
Table 123. Regeneron Company Information, Head Office, and Major Competitors	131
Table 124. Regeneron Major Business	131
Table 125. Regeneron Anticancer Drugs Product and Solutions	132
Table 126. Regeneron Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)	132
Table 127. Innovent Company Information, Head Office, and Major Competitors	134
Table 128. Innovent Major Business	134
Table 129. Innovent Anticancer Drugs Product and Solutions	135
Table 130. Innovent Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)	136
Table 131. Hengrui Medicine Company Information, Head Office, and Major Competitors	137
Table 132. Hengrui Medicine Major Business	137
Table 133. Hengrui Medicine Anticancer Drugs Product and Solutions	138
Table 134. Hengrui Medicine Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)	138
Table 135. Key Raw Materials Lists	140
Table 136. Raw Materials Key Suppliers Lists	141
Table 137. Anticancer Drugs Distributors List	144
Table 138. Anticancer Drugs Customers List	146
Table 139. Anticancer Drugs Market Trends	148
Table 140. Anticancer Drugs Market Drivers	149
Table 141. Anticancer Drugs Market Challenges	150
Table 142. Anticancer Drugs Market Restraints	151
Table 143. Research Programs/Design for This Report	154
Table 144. Key Data Information from Secondary Sources	158
Table 145. Key Data Information from Primary Sources	159
Table 146. Authors List of This Report	160


List of Figures

Figure 1. Product Picture of Anticancer Drugs	1
Figure 2. Global Anticancer Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)	2
Figure 3. Global Anticancer Drugs Market Share by Type: 2023	3
Figure 4. Global Anticancer Drugs Market Share by Type: 2030	3
Figure 5. Chemotherapy Product Picture	4
Figure 6. Targeted Therapy Product Picture	6
Figure 7. Cancer Immunotherapy Product Picture	7
Figure 8. Global Anticancer Drugs Market Value by Application (2024-2030) & (US$ Million)	9
Figure 9. Global Anticancer Drugs Market Share by Application: 2023	10
Figure 10. Global Anticancer Drugs Market Share by Application: 2030	10
Figure 11. Lung Cancer	11
Figure 12. Breast Cancer	12
Figure 13. Prostate Cancer	13
Figure 14. Blood-related Cancer	14
Figure 15. Global Anticancer Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030	15
Figure 16. Global Anticancer Drugs Market Size (2019-2030) & (US$ Million)	15
Figure 17. Anticancer Drugs Report Years Considered	17
Figure 18. Global Anticancer Drugs Revenue Share by Manufacturers in 2023	20
Figure 19. Global 5 Largest Anticancer Drugs Players: Market Share by Revenue in Anticancer Drugs in 2023	25
Figure 20. Global 10 Largest Anticancer Drugs Players: Market Share by Revenue in Anticancer Drugs in 2023	26
Figure 21. Global Anticancer Drugs Market Size by Region (US$ Million): 2019-2030	31
Figure 22. North America Anticancer Drugs Revenue Market Share by Country (2019-2030)	34
Figure 23. U.S. Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)	34
Figure 24. Canada Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)	35
Figure 25. Mexico Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)	35
Figure 26. Europe Anticancer Drugs Revenue Market Share by Country (2019-2030)	37
Figure 27. Germany Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)	38
Figure 28. France Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)	38
Figure 29. U.K. Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)	39
Figure 30. Italy Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)	39
Figure 31. Russia Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)	40
Figure 32. Asia Pacific Anticancer Drugs Revenue Market Share by Region (2019-2030)	42
Figure 33. China Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)	42
Figure 34. Japan Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)	43
Figure 35. South Korea Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)	43
Figure 36. India Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)	44
Figure 37. Australia Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)	44
Figure 38. Southeast Asia Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)	45
Figure 39. Brazil Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)	46
Figure 40. Middle East and Africa Anticancer Drugs Revenue Market Share by Country (2019-2030)	48
Figure 41. Middle East Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)	48
Figure 42. Africa Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)	49
Figure 43. Global Revenue Market Share of Anticancer Drugs by Type (2019-2030)	51
Figure 44. Global Revenue Market Share of Anticancer Drugs by Application (2019-2030)	53
Figure 45. Merck & Co Recent Developments and Future Plans	97
Figure 46. Anticancer Drugs Value Chain	140
Figure 47. Anticancer Drugs Production Process (Capsule)	141
Figure 48. Anticancer Drugs Production Process (Injection)	142
Figure 49. Anticancer Drugs Production Process (Tablet)	142
Figure 50. Channels of Distribution (Direct Vs Distribution)	143
Figure 51. Bottom-up and Top-down Approaches for This Report	156
Figure 52. Data Triangulation	157
Figure 53. Key Executives Interviewed	159

Description

The global Anticancer Drugs market was valued at US$ 190,012 million in 2023 and is anticipated to reach US$ 391,003 million by 2030, witnessing a CAGR of 11.26% during the forecast period 2024-2030.

North American market for Anticancer Drugs is estimated to increase from $ 104,835 million in 2023 to reach $ 207,068 million by 2030, at a CAGR of 10.7% during the forecast period of 2024 through 2030.

Asia-Pacific market for Anticancer Drugs is estimated to increase from $ 39,518 million in 2023 to reach $ 89,042 million by 2030, at a CAGR of 12.38% during the forecast period of 2024 through 2030.

Market Segmentation